OKUR MEXC RealStocks
Own real OKUR shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 22:28:00. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
OnKure Therapeutics, Inc. (OKUR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $3.01, with a market capitalization of $139.43M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.01 to $5.38. This page covers its latest market performance, valuation, price trends and company information.
$139.43M | |
$3.33 | |
$3.36 | |
$2.93 | |
$3.36 | |
271.33K | |
314.09K | |
-- | |
$5.38 | |
$2.01 | |
-- | |
-- |
OnKure Therapeutics, Inc. (OKUR) is trading at $3.01 in after-hours trading as of 2026-11-12 20:59:23, unchanged from the regular-session close of $3.01.
After-hours trading shows how investors are pricing OKUR after the regular session closes. The current after-hours price is near the regular-session close, indicating neutral after-hours sentiment.
Over the past seven days, OnKure Therapeutics, Inc. (OKUR) moved from $2.50 to $3.01, representing a gain of 20.40% ($0.51).
The stock traded between $2.31 and $3.59 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 468.46 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 29.7%
OKUR is currently trading at $3.01, placing it 29.7% of the way from its 52-week low of $2.01 to its 52-week high of $5.38. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Kα. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 45 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for OnKure Therapeutics, Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of OnKure Therapeutics, Inc. (OKUR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to OKUR, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between OKUR shares and USD.
OKUR Shares to USD
1.00 OKUR shares = 3.01 USD
Calculations are estimates based on the latest available price and are for reference only.